CAMAF Member Option Guides & Info

Cryo-Save (Brochure)

Issue link: https://www.hub.camaf.co.za/i/598647

Contents of this Issue

Navigation

Page 16 of 33

17 CORD BLOOD STEM CELLS - SAVE TODAY, PROTECT TOMORROW Over 4,000 trials involving Stem Cells with over 200 of these trials using Umbilical Cord Blood Stem Cells. Clinical trials analyse new medical treatments for their safety, efficiency and potentially adverse effects in humans. WHAT THE FUTURE HOLDS EXPERT OPINIONS 4,000 TRAILS ON STEM CELLS Dr. Marcin Jurga R&D Manager at Cryo-Save's flagship lab, Niel, Belgium "Apart from current therapies using Haematopoietic Stem Cells, from Umbilical Cord Blood, there is an incresing number of clinical trials using Mesenchymal Stem Cells. These are used in researching a broader scope of applications, such as treatments of: Nervous system diseases, Graft-vs-Host disease, orthopedic injuries and disorders, cardiovascular illnesses, diabetic patients, but also in tissue engineering applications where entire organs can be produced. The future of Stem Cell applications is yet to show its full potential." Dr. Luis Madero Director of Oncohematology, Niño Jesús Hospital, Madrid, Spain "There are clinical trials for the use of Cord Blood Cells for non-hematopoietic diseases in children for cases of cerebral palsy and diabetes. The information reported on the cerebral palsy trials has given some positive preliminary results. The experience in diabetes is still limited and more data need to be gathered before any conclusion can be drawn." Prof. Dr. Daniel Surbek Department of Obstetrics and Gynecology, Inselspital Bern, Switzerland "Evidence from recent studies suggests that transplantation of Stem Cells from the Umbilical Cord may be used as treatment for severe perinatal brain damage due to preterm delivery or birth asphyxia. Transplanted Stem Cells may regenerate damaged neural tissue and central nervous system function. Several clinical trials in children affected by cerebral palsy are ongoing." Dr. Csaba Papp Associate professor, medical geneticist, Semmelweis University, Buda pest, Hungary "Together with the Umbilical Cord Blood, the preservation of the Cord Tissue is not only a possibility for obtaining mesenchymal Stem Cells, but for yielding other Cells that are important for future Stem Cell therapies."

Articles in this issue

view archives of CAMAF Member Option Guides & Info - Cryo-Save (Brochure)